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 Guest Editorial 1 
Addressing the threat posed by chlamydial infection to koalas in Australia: Use of rapid 2 
diagnostic tests ‘in the field’ 3 
 4 
The paper by Hanger et al. (2012) published in this issue of TVJ compares the 5 
performance of a rapid antigen detection test with that of a quantitative PCR assay to detect 6 
chlamydial infections in koalas (Phascolarctos cinereus). Chlamydial infections are 7 
extremely important in wild koalas, as they have the potential to drive this already-threatened 8 
animal to extinction. Chlamydiosis has contributed, in combination with habitat loss, climate 9 
change and injuries caused by cars or dogs, to both the rapid decline and localised extinction 10 
of the wild koala population. In fact, chlamydial keratoconjunctivitis was suggested to be the 11 
possible cause of the decline in the koala population between 1885 and 1930 in Eastern 12 
Australia (Cockram and Jackson, 1981). Alarmingly, in Queensland, surveys from 2001 to 13 
2008 suggest that koala numbers have dropped as much as 45% and 15% in urban areas and 14 
‘bushland’, respectively.  15 
 16 
Koalas can become infected with two different chlamydial species, Chlamydia pecorum 17 
and C. pneumoniae. The koala biovar of C. pneumoniae causes rhinitis and pneumonia, 18 
whereas infection with C. pecorum leads to more severe diseases like keratoconjunctivitis 19 
possibly leading to blindness. In female koalas, C. pecorum can cause vaginitis, cystitis and 20 
ovarian cysts with infertility as a possible sequela. The separation of the family 21 
Chlamydiaceae into two genera, Chlamydia and Chlamydophila, based on 16S rRNA 22 
sequence analysis was proposed by Everett et al. (1999). As this taxonomic division has not 23 
subsequently been consistently used in the literature, and has generally not been accepted by 24 
 the scientific community, it was recently proposed to abandon the genus name Chlamydophila 25 
and to transfer all the current Chlamydophila spp. into one genus Chlamydia.  26 
 27 
In the current nomenclature (Kuo et al., 2011), the family Chlamydiaceae contains nine 28 
species: C. trachomatis, C. pneumoniae, C. psittaci, C. pecorum, C. abortus, C. suis, C. felis, 29 
C. caviae, and C. muridarum. C. pecorum has been isolated from ruminants, swine and koala 30 
(Pospischil et al., 2010). Strains detected in koalas are monophyletic in nature, as 31 
demonstrated when using novel molecular markers (Marsh et al., 2011). The species C. 32 
pneumoniae includes three biovars: human, horse and koala (Kuo et al., 2011). Whereas 33 
human isolates are essentially clonal, isolates of animal origin (amphibian, reptilian, equine 34 
and marsupial) are much more diverse and at least two separate animal-to-human cross-35 
species transfer events are suggested to have occurred in the evolution of this pathogen 36 
(Mitchell et al., 2010). 37 
  38 
The outcome of field studies depends greatly on the availability and proper collection 39 
of field samples. Swabbing of different anatomical sites is best performed using ‘flocked’ 40 
swabs (Chernesky et al., 2006) or cytobrushes (Polkinghorne et al., 2009), to obtain the 41 
epithelial cells that harbour these obligate intracellular organisms. The type of sample 42 
submitted, the amount of DNA/viable organisms present in the sample, the preservation and 43 
possible contamination of the sample, and the length and type of transportation are crucial 44 
factors influencing the correct diagnosis of chlamydial infections. Importantly, recently 45 
developed rapid tests enable direct field-testing and diagnosis of chlamydial infections 46 
without transportation of samples. Many commercially available rapid antigen detection tests 47 
have been developed over the last 25 years primarily for the detection of C. trachomatis 48 
 infection in humans. As most of these tests are based on the family-specific LPS antigen they 49 
are also suitable for the detection of other chlamydial species.  50 
 51 
In a comparison of nine antigen detection kits for the detection of chlamydial 52 
urogenital infections in koalas, the Clearview test performed best with a sensitivity of 91% 53 
(Wood and Timms, 1992). Contrasting results were obtained with the same test when it was 54 
used to detect C. abortus in ovine fetal membranes (Wilsmore and Davidson, 1991), and C. 55 
psittaci in conjunctival and cloacal samples from turkeys (Vanrompay et al., 1994), 56 
respectively. These inconsistencies can probably be explained by variation between the 57 
sampling sites and correlation with infectious load, as reported by Hanger et al. (2012) in this 58 
issue of TVJ. In the laboratory, nucleic acid amplification tests (NAATs) remain the ‘gold 59 
standard’ for detecting chlamydial infections in domestic and wild animals (Sachse et al., 60 
2009). Under field conditions, rapid tests may be helpful in obtaining a prompt diagnosis of 61 
active chlamydial infection. Unfortunately, subclinically infected animals shedding low levels 62 
of organisms may not be detected. Furthermore, differentiating C. pneumoniae from the more 63 
prevalent and pathogenic C. pecorum, or the detection of other Chlamydia spp. or Chlamydia-64 
like organisms, or mixed chlamydial infections is not possible using such assays.  65 
 66 
Despite these limitations, the Clearview assay may be a useful adjunct test in 67 
diagnosing active chlamydial infections in koalas due to its portability, ease-of-use and short 68 
turn-around time (Hanger et al., 2012). Rapid tests in the field might also be useful to screen 69 
animals prior to treatment or vaccination. Carey et al. (2010) tested a multi-subunit vaccine 70 
against Chlamydia spp. that was found to be safe and effective in healthy female koalas. Early 71 
trials of whole cell vaccines to prevent trachoma were shown to have the potential to enhance 72 
inflammation when vaccination was performed in naturally-infected individuals (Huston et 73 
 al., 2012). Thus, vaccination of subclinically infected koalas may have an adverse clinical 74 
outcome under certain circumstances, which increases the importance of rapid and accurate 75 
screening prior to vaccination. It is also important to consider that detection of subclinically 76 
infected animals can be confounded by false-negative Clearview test results.  The prerequisite 77 
need to only vaccinate healthy koalas was circumvented very recently in a study by Kollipara 78 
et al. (2012), where the multi-subunit vaccine tested did not exacerbate existing lesions when 79 
administered to previously infected koalas. 80 
 81 
In summary, the study by Hanger et al. (2012) highlights that NAATs remain the gold 82 
standard in diagnosing chlamydial infections in animals and humans, but field conditions 83 
have to be considered when using alternative ‘on-site’ rapid tests. In ‘field’ settings the 84 
handling and treatment of captive or wild koalas can be problematic, and appropriate sample 85 
collection, preservation and transportation can be challenging. Despite detailed planning, the 86 
outcome of field studies can be hampered by logistical problems and careful consideration is 87 
required before such studies are performed on wild and captive koalas or indeed on other 88 
wildlife species. 89 
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